MB
Microbix Biosystems Inc.
MBXBF · OTC
$0.22 +0.00% (+$0.00)
1M +1.82%
Market Cap $41.7M
P/E Ratio -
Div. Yield -
ROE 16.97%
Bulios Fair Price
$0.17
21.7% downside
Current Price
$0.22
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MBXBF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
79 /100
Cheap P/B 1.72x
P/S 2.71x
EV/EBITDA N/A
Growth
22 /100
Declining Book val. growth 3.72%
Rev. growth 0.82%
FCF growth N/A
Profitability
18 /100
Weak Net margin 28.60%
Op. margin 28.53%
FCF margin 25.22%
Quality
6 /100
Poor ROE 16.97%
ROA 12.94%
Asset turnover 0.45x
Debt
69 /100
Low Current ratio 6.89x
Int. coverage -3.82x
Debt/Equity 0.28x
Stability
24 /100
Unstable Rev. volatility 43.14%
EPS volatility 5,061.24%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MBXBF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Cameron L. Groome
Employees
100
Headquarters
Mississauga
Upcoming events
17 DEC
Earnings
Upcoming earnings report